Medicine and Dentistry
Breast Cancer
100%
Neoplasm
96%
Malignant Neoplasm
70%
Health Care Cost
51%
Disease
45%
Cost-Effectiveness Analysis
44%
BRCA1
41%
Prostate Cancer
38%
Tamoxifen
38%
Pleura Effusion
36%
Melphalan
34%
Radiation Therapy
31%
Clinical Trial
29%
Chemoprophylaxis
29%
Nodular Melanoma
28%
Tumor Xenograft
27%
Adjuvant Chemotherapy
27%
Lonidamine
27%
Breast Tumor
27%
Xenograft
25%
Hormone Therapy
24%
Ovariectomy
24%
Cancer Diagnosis
23%
Disease Free Survival
22%
Tumor Progression
22%
BRCA2
21%
Ovarian Cancer
21%
Overall Survival
20%
Prostate Specific Antigen
20%
Prostatectomy
20%
External Beam Radiotherapy
19%
Fluorouracil
19%
Hematologic Malignancy
19%
Limb Perfusion
18%
Gemcitabine
18%
Pancreas Cancer
18%
Placebo
18%
Colon Cancer
18%
Hyperglycemia
18%
T Cell
18%
Gene Transfer
18%
Lymphoproliferative Disease
18%
Glioblastoma
18%
Hypersensitivity
18%
Septic Shock
18%
Hydroxychloroquine
18%
Bevacizumab
18%
Symptomatic Treatment
18%
Surgery
17%
Medicare
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
85%
Breast Cancer
82%
Clinical Trial
76%
Disease
69%
Chemotherapy
66%
Malignant Neoplasm
63%
Placebo
38%
Melanoma
37%
Hydroxychloroquine
36%
Phase I Trials
31%
Biological Marker
30%
Progression Free Survival
28%
Melphalan
28%
Prostate Cancer
27%
Glioblastoma
27%
Lonidamine
27%
Solid Malignant Neoplasm
24%
Overall Survival
24%
Congestive Heart Failure
22%
Prevalence
22%
Mesothelioma
21%
Gemcitabine
19%
Kidney Metastasis
19%
Adenosine Triphosphate
19%
Fluorouracil
19%
Cotinine
19%
Temozolomide
18%
Estramustine
18%
Interferon
18%
Pharmacogenetics
18%
Erethism
18%
Bevacizumab
18%
Sorafenib
18%
Hyperuricemia
18%
Ovary Cancer
18%
Nude Mouse
17%
Heart Failure
16%
Tumor Growth
16%
Pleura Mesothelioma
15%
Varenicline
15%
Renal Cell Carcinoma
14%
Randomized Clinical Trial
14%
Maximum Tolerated Dose
13%
Chronic Obstructive Lung Disease
13%
Statistical Modeling
13%
Breast Tumor
13%
Hormone Cancer Therapy
13%
Endocrine Therapy
12%
Symptom
12%
Staurosporine Derivative
11%
Keyphrases
Clinical Trials
76%
Concurrent Cancer
36%
Tumor
34%
Phase I Trial
29%
Non-ignorable
28%
Smoking Cessation
28%
Treatment Effect
27%
Nonignorability
27%
Radical Prostatectomy
27%
Interferon-α (IFN-α)
27%
Breast Cancer
27%
Hydroxychloroquine
27%
Brain Injury
26%
Confidence Interval
25%
Cost-effectiveness
24%
Cigarette
23%
Glioblastoma Cell Lines
23%
Radiation Therapy
23%
Statistical Analysis
22%
Immature Rats
21%
Autophagy Inhibition
21%
Chemoprevention
20%
Weibull
19%
Mechanical Assistance
19%
Colorectal Cancer
18%
Placebo
18%
Local Sensitivity
18%
Cdc2
18%
Tumor Xenograft
18%
Post-transplant Lymphoproliferative Disorder
18%
AIDS/HIV
18%
Missing at Random
18%
Event Time
18%
Estramustine
18%
Adjuvant Chemotherapy
18%
Gene Transfer
18%
In Vivo Tumor Growth
18%
Growth Experiment
18%
Adenoviral
18%
Congestive Heart Failure
18%
Decision Analysis
18%
Bayesian Estimation
18%
Hypoxic-ischemic Brain Injury
18%
Intrapleural
18%
Unmeasured Confounders
16%
5-fluorouracil (5-FU)
16%
BRCA1, BRCA2
15%
Sensitivity Analysis
15%
Malignant Pleural Mesothelioma
15%
Mammography
15%
